MYOLYN and Brooks Rehabilitation Formalize Decade-Long Collaboration to Drive the Next Generation of Rehabilitation

MYOLYN, a medical technology company dedicated to making functional electrical stimulation (FES) therapy more accessible, today announced a formal partnership with Brooks Rehabilitation, Florida’s top-ranked rehabilitation hospital according to U.S. News & World Report. The agreement builds on ten years of collaborative work and establishes a structured framework for advancing rehabilitation technology that serves people living with neurological injuries or illness.

At the heart of the partnership is MYOLYN’s FES therapy technology, including the MyoCycle® FES Cycling Therapy System—a device designed to be affordable, intuitive, and effective for both clinical and home settings. Brooks Rehabilitation brings more than five decades of expertise in complex rehabilitation care, including treatment of spinal cord and brain injuries, stroke, multiple sclerosis, traumatic amputations, and multi-trauma conditions, along with a national reputation for clinical innovation and outcomes-driven research.

“This partnership reflects what we’ve known for years: the best rehabilitation technology is developed alongside the patients and clinicians who depend on it. MYOLYN has consistently demonstrated a commitment to listening—to understanding what our patients need in the clinic and at home, not just what is technically feasible. Formalizing this relationship gives us the structure to share clinical insights more systematically and to pursue the kind of rigorous research that moves the field forward for people living with neurological injuries or illness.”

— Robert McIver, PT, DPT, NCS, Director of the Center for Innovation, Brooks Rehabilitation

Under the terms of the partnership, MYOLYN will draw on Brooks’ clinical knowledge and patient feedback to guide the research and development of its medical devices. The two organizations will also collaborate on funding applications for clinical investigations examining the benefits of MYOLYN’s technology for Brooks Rehabilitation patients. By embedding clinical expertise directly into the development process, both organizations aim to produce solutions that are meaningfully responsive to real-world needs—not just technically sound, but safe, effective, and accessible.

“Our mission has always been to create rehabilitation technology that truly meets the needs of both patients and clinicians. We have been working with Brooks Rehabilitation for 10 years now, and we are ecstatic to finally formalize our partnership. With this agreement, we have another direct line of communication between world-class rehabilitation professionals and our innovative development team, which will help ensure that our products are safe, effective, and accessible with minimal risks.”

— Matthew Bellman, Ph.D., Co-Founder and Chief Technology Officer, MYOLYN

Brooks’ Center for Innovation has been a key partner in MYOLYN’s device development since the earliest stages. Within the Neuro Recovery Center, a state-of-the-art neurorehabilitation facility that provides access to specialized equipment after traditional therapy ends, Brooks supported clinical testing and consultation on both the first and second generations of the MyoCycle system. That ongoing collaboration has provided MYOLYN’s engineering team with direct clinical feedback to refine each iteration of the device and support new product development.